当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:463.53亿  总市值:584.29亿
流通股本:21.18亿   总股本:26.70亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金20,516,123,126.5510,036,720,780.242,051,276,895.930,773,141,374.91
  收到的税费返还194,893,862.38120,411,573.95383,454,967.68253,122,403.14
  收到其他与经营活动有关的现金1,258,632,548.5947,760,302.74880,686,797.761,185,817,322.69
  经营活动现金流入小计21,969,649,537.4311,104,892,656.8943,315,418,661.3432,212,081,100.74
  购买商品、接受劳务支付的现金6,783,016,303.123,339,525,252.6214,670,081,647.9811,176,691,619.61
  支付给职工以及为职工支付的现金6,239,182,119.283,197,848,208.0811,245,753,461.998,507,722,635.45
  支付的各项税费1,419,992,409686,177,071.612,674,701,462.592,054,188,939.25
  支付其他与经营活动有关的现金5,103,506,291.352,732,744,336.769,511,655,210.437,091,709,340.72
  经营活动现金流出小计19,545,697,122.759,956,294,869.0738,102,191,782.9928,830,312,535.03
  经营活动产生的现金流量净额2,423,952,414.681,148,597,787.825,213,226,878.353,381,768,565.71
二、投资活动产生的现金流量:
  收回投资收到的现金500,064,407.2347,569,016.662,450,861,304.172,217,629,391.75
  取得投资收益收到的现金180,265,477.55122,511,415.01792,055,953.78226,566,471.52
  处置固定资产、无形资产和其他长期资产收回的现金净额52,312,018.5543,817,389.5981,902,433.5242,136,833.16
  处置子公司及其他营业单位收到的现金净额101,778,535.865,841,904.03230,623,552181,376,314.58
  收到的其他与投资活动有关的现金72,872,511.1910,550,546.86166,815,422.57220,302,827.77
  投资活动现金流入小计907,292,950.29590,290,272.153,722,258,666.042,888,011,838.78
  购建固定资产、无形资产和其他长期资产支付的现金2,428,860,345.661,091,365,638.924,448,451,634.913,168,540,323.03
  投资支付的现金1,450,737,987.65671,162,856.2937,720,065.36892,030,051.91
  取得子公司及其他营业单位支付的现金307,813,252.43297,095,544.2533,976,446.733,976,446.7
  支付其他与投资活动有关的现金1,147,979,675.1259,950,736.18447,876,807.8305,297,457.93
  投资活动现金流出小计5,335,391,260.842,319,574,775.555,868,024,954.774,399,844,279.57
  投资活动产生的现金流量净额-4,428,098,310.55-1,729,284,503.4-2,145,766,288.73-1,511,832,440.79
三、筹资活动产生的现金流量:
  吸收投资收到的现金135,137,918.1925,032,000218,263,053.21195,288,551.57
  其中:子公司吸收少数股东投资收到的现金135,137,918.1925,032,000218,263,053.21195,288,551.57
  取得借款收到的现金13,103,690,508.147,821,034,931.6336,258,205,827.7426,346,546,129.08
  收到其他与筹资活动有关的现金690,410,284.88107,291,170.84857,550,499.2327,480,095.01
  筹资活动现金流入小计13,929,238,711.217,953,358,102.4737,334,019,380.1526,869,314,775.66
  偿还债务支付的现金10,291,818,526.936,317,691,422.1136,493,980,610.5426,629,633,045.31
  分配股利、利润或偿付利息支付的现金659,524,027.47250,088,995.612,315,321,975.782,060,586,501.09
  其中:子公司支付给少数股东的股利、利润169,124,170.947,727,047.95370,679,415.07351,893,007.84
  支付其他与筹资活动有关的现金301,892,144.84107,382,486.231,768,806,300.981,423,521,850.45
  筹资活动现金流出小计11,253,234,699.246,675,162,903.9540,578,108,887.330,113,741,396.85
  筹资活动产生的现金流量净额2,676,004,011.971,278,195,198.52-3,244,089,507.15-3,244,426,621.19
四、汇率变动对现金及现金等价物的影响-222,600,992.35-158,570,564.25-176,810,748.88-80,826,833.37
五、现金及现金等价物净增加额449,257,123.75538,937,918.69-353,439,666.41-1,455,317,329.64
  加:期初现金及现金等价物余额9,038,010,120.79,038,010,120.79,391,449,787.119,391,449,787.11
  期末现金及现金等价物余额9,487,267,244.459,576,948,039.399,038,010,120.77,936,132,457.47
补充资料:
  净利润2,148,928,430.32-4,247,929,628.38-
  资产减值准备14,942,862.94-150,063,042.97-
  固定资产和投资性房地产折旧833,695,167.35-1,782,627,838.46-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧833,695,167.35-1,782,627,838.46-
  无形资产摊销678,791,505.45-1,362,330,066.18-
  长期待摊费用摊销120,485,813.61-211,406,402.92-
  处置固定资产、无形资产和其他长期资产的损失-195,231.96--69,350,406.88-
  固定资产报废损失1,703,734.07-9,848,475.82-
  公允价值变动损失-273,651,844.51-322,268,457.29-
  财务费用529,998,254.39-1,109,132,867.54-
  投资损失-1,493,305,373.4--3,763,778,024.02-
  递延所得税64,753,657.65--326,000,447.95-
  其中:递延所得税资产减少-29,558,937.83--253,876,291.87-
    递延所得税负债增加94,312,595.48--72,124,156.08-
  存货的减少443,646,870.02-1,236,227,214.47-
  经营性应收项目的减少319,646,036.81--1,011,067,423.03-
  经营性应付项目的增加-1,505,908,352.79--748,906,006.61-
  不涉及现金收支的投资和筹资活动金额其他项目157,105,861.54-1,066,676,562.95-
  现金的期末余额9,487,267,244.45-9,038,010,120.7-
  减:现金的期初余额9,038,010,120.7-9,391,449,787.11-
  现金及现金等价物的净增加额449,257,123.75--353,439,666.41-
公告日期2026-08-262026-04-292026-03-252025-10-29
审计意见(境内)标准无保留意见
TOP↑